Original Research
Published on 31 Aug 2022
High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.936670
- 2,255 views
- 2 citations
Type at least 3 characters
1,748 articles
Articles
Original Research
Published on 31 Aug 2022
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.994366
- 1,760 views
- 2 citations
Original Research
Published on 30 Aug 2022
Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.959949
- 3,219 views
- 5 citations
Original Research
Published on 30 Aug 2022
An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.992387
- 2,891 views
- 3 citations
Case Report
Published on 29 Aug 2022
Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.951362
- 1,886 views
- 2 citations
Case Report
Published on 29 Aug 2022
Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.960914
- 3,288 views
- 3 citations
Original Research
Published on 26 Aug 2022
Socioeconomic status-based survival disparities and nomogram prediction for patients with multiple myeloma: Results from American and Chinese populations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.941714
- 1,935 views
- 3 citations
Original Research
Published on 26 Aug 2022
Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.978755
- 2,314 views
- 3 citations
Review
Published on 25 Aug 2022
Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.949435
- 9,642 views
- 9 citations
Review
Published on 25 Aug 2022
The hedgehog pathway in hematopoiesis and hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.960943
- 2,918 views
- 9 citations
Original Research
Published on 23 Aug 2022
Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.941347
- 3,232 views
- 4 citations
Original Research
Published on 22 Aug 2022
Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.989258
- 1,749 views
- 2 citations
Mini Review
Published on 22 Aug 2022
The role of the bone microenvironment in regulating myeloma residual disease and treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.999939
- 3,628 views
- 4 citations
Review
Published on 18 Aug 2022
Hypoxic stress and hypoxia-inducible factors in leukemias
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.973978
- 3,828 views
- 7 citations
Case Report
Published on 18 Aug 2022
Sodium oligomannate combined with rivastigmine may improve cerebral blood flow and cognitive impairment following CAR-T cell therapy: A case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.902301
- 2,299 views
- 6 citations
Original Research
Published on 18 Aug 2022
Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: A SEER-based study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.989366
- 3,427 views
- 5 citations